NCT06120374 Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC Status RECRUITING Phase N/A
NCT06120127 Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence Status RECRUITING Phase PHASE2
NCT06102057 PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC Status RECRUITING Phase PHASE2
NCT06090864 ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells Status RECRUITING Phase PHASE1/PHASE2
NCT06019520 Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity Status UNKNOWN Phase NA
NCT05981703 A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05979818 Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer Status RECRUITING Phase PHASE1
NCT05978193 Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT05975749 Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer Status RECRUITING Phase PHASE2
NCT05939661 A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer Status RECRUITING Phase PHASE2
NCT05935579 Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE2
NCT05935098 BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors Status TERMINATED Phase PHASE1
NCT05926492 A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma Status RECRUITING Phase PHASE2
NCT05926427 Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement Status RECRUITING Phase PHASE2
NCT05916755 Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform Status RECRUITING Phase N/A
NCT05909332 Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) Status RECRUITING Phase PHASE3
NCT05862610 The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC Status NOT_YET_RECRUITING Phase PHASE2